Pharmacological treatments available in Brazil for multiple sclerosis patients: Integrative review

×

Error message

User warning: The following theme is missing from the file system: journalijdr. For information about how to fix this, see the documentation page. in _drupal_trigger_error_with_delayed_logging() (line 1138 of /home2/journalijdr/public_html/includes/bootstrap.inc).

International Journal of Development Research

Volume: 
12
Article ID: 
25543
5 pages
Research Article

Pharmacological treatments available in Brazil for multiple sclerosis patients: Integrative review

Renata Abílio Diniz Leite Medeiros

Abstract: 

Introduction: Multiple sclerosis (MS) affects a large number of people worldwide, in Brazil the estimate is 40,000 people who have the disease. There is no cure for multiple sclerosis, but currently there are several treatments available both by the public network and by the private network in Brazil. Objective: It is to know the pharmacological treatments available in Brazil for patients with multiple sclerosis. Methodology: Fhi an integrative review of the literature, in the Databases PubMed, capes and VHL. Result and discussion: Treatment for multiple sclerosis is divided into imunomodulators that are considered the first-line drugs and exist the second-line. Conclusion: Thes medications are effective in controlling multiple sclerosis.

DOI: 
https://doi.org/10.37118/ijdr.25543.10.2022
Download PDF: